Literature DB >> 18682571

Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment.

Connie Cheung1, Frank J Gonzalez.   

Abstract

Cytochrome P450s (P450s) are important enzymes involved in the metabolism of xenobiotics, particularly clinically used drugs, and are also responsible for metabolic activation of chemical carcinogens and toxins. Many xenobiotics can activate nuclear receptors that in turn induce the expression of genes encoding xenobiotic metabolizing enzymes and drug transporters. Marked species differences in the expression and regulation of cytochromes P450 and xenobiotic nuclear receptors exist. Thus, obtaining reliable rodent models to accurately reflect human drug and carcinogen metabolism is severely limited. Humanized transgenic mice were developed in an effort to create more reliable in vivo systems to study and predict human responses to xenobiotics. Human P450s or human xenobiotic-activated nuclear receptors were introduced directly or replaced the corresponding mouse gene, thus creating "humanized" transgenic mice. Mice expressing human CYP1A1/CYP1A2, CYP2E1, CYP2D6, CYP3A4, CY3A7, pregnane X receptor, and peroxisome proliferator-activated receptor alpha were generated and characterized. These humanized mouse models offer a broad utility in the evaluation and prediction of toxicological risk that may aid in the development of safer drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682571      PMCID: PMC2597361          DOI: 10.1124/jpet.108.141242

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  70 in total

1.  Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.

Authors:  Y Masubuchi; T Iwasa; S Hosokawa; T Suzuki; T Horie; S Imaoka; Y Funae; S Narimatsu
Journal:  J Pharmacol Exp Ther       Date:  1997-09       Impact factor: 4.030

2.  An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.

Authors:  S A Kliewer; J T Moore; L Wade; J L Staudinger; M A Watson; S A Jones; D D McKee; B B Oliver; T M Willson; R H Zetterström; T Perlmann; J M Lehmann
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

3.  Peroxisome proliferator activated receptor-alpha expression in human liver.

Authors:  C N Palmer; M H Hsu; K J Griffin; J L Raucy; E F Johnson
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

4.  Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

Authors:  J M Peters; R C Cattley; F J Gonzalez
Journal:  Carcinogenesis       Date:  1997-11       Impact factor: 4.944

Review 5.  Mice as clinically relevant models for the study of cytochrome P450-dependent metabolism.

Authors:  S Muruganandan; C J Sinal
Journal:  Clin Pharmacol Ther       Date:  2008-03-19       Impact factor: 6.875

6.  Generation of mice transgenic for human CYP2C18 and CYP2C19: characterization of the sexually dimorphic gene and enzyme expression.

Authors:  Susanne Löfgren; R Michael Baldwin; Masahiro Hiratsuka; Annelie Lindqvist; Anne Carlberg; Sarah C Sim; Meint Schülke; Michael Snait; Anne Edenro; Ronny Fransson-Steen; Ylva Terelius; Magnus Ingelman-Sundberg
Journal:  Drug Metab Dispos       Date:  2008-02-14       Impact factor: 3.922

Review 7.  Substrates of human hepatic cytochrome P450 3A4.

Authors:  A P Li; D L Kaminski; A Rasmussen
Journal:  Toxicology       Date:  1995-12-15       Impact factor: 4.221

8.  Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice.

Authors:  Melanie A Felmlee; Hoi-Kei Lon; Frank J Gonzalez; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2007-11-29       Impact factor: 3.922

Review 9.  Chimeric mice with humanized liver.

Authors:  Miki Katoh; Chise Tateno; Katsutoshi Yoshizato; Tsuyoshi Yokoi
Journal:  Toxicology       Date:  2007-11-22       Impact factor: 4.221

10.  Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.

Authors:  Martin Holdener; Edith Hintermann; Monika Bayer; Antje Rhode; Evelyn Rodrigo; Gudrun Hintereder; Eric F Johnson; Frank J Gonzalez; Josef Pfeilschifter; Michael P Manns; Matthias von G Herrath; Urs Christen
Journal:  J Exp Med       Date:  2008-05-12       Impact factor: 14.307

View more
  42 in total

Review 1.  Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicity.

Authors:  Frank J Gonzalez; Zhong-Ze Fang; Xiaochao Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-04-02       Impact factor: 4.481

2.  Glucuronidation of drugs and drug-induced toxicity in humanized UDP-glucuronosyltransferase 1 mice.

Authors:  Yuki Kutsuno; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

3.  Effects of ketoconazole on the biodistribution and metabolism of [11C]loperamide and [11C]N-desmethyl-loperamide in wild-type and P-gp knockout mice.

Authors:  Nicholas Seneca; Sami S Zoghbi; H Umesha Shetty; Edward Tuan; Pavitra Kannan; Andrew Taku; Robert B Innis; Victor W Pike
Journal:  Nucl Med Biol       Date:  2010-04       Impact factor: 2.408

Review 4.  A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.

Authors:  A S Khazali; A M Clark; A Wells
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

Review 5.  P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity.

Authors:  Karl-Dimiter Bissig; Weiguo Han; Mercedes Barzi; Nataliia Kovalchuk; Liang Ding; Xiaoyu Fan; Francis P Pankowicz; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2018-08-09       Impact factor: 3.922

Review 6.  Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.

Authors:  Sarah E Rowe; Jenna E Beam; Brian P Conlon
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

7.  Ligand diversity of human and chimpanzee CYP3A4: activation of human CYP3A4 by lithocholic acid results from positive selection.

Authors:  Santosh Kumar; Huan Qiu; Numan Oezguen; Holger Herlyn; James R Halpert; Leszek Wojnowski
Journal:  Drug Metab Dispos       Date:  2009-03-19       Impact factor: 3.922

8.  Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

Authors:  Carolyn D DuSell; Erik R Nelson; Bryan M Wittmann; Jackie A Fretz; Dmitri Kazmin; Russell S Thomas; J Wesley Pike; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-09

Review 9.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

Review 10.  Rodent models of alcoholic liver disease: of mice and men.

Authors:  Elizabeth Brandon-Warner; Laura W Schrum; C Max Schmidt; Iain H McKillop
Journal:  Alcohol       Date:  2012-09-07       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.